Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 3Melanoma 3Lung Neoplasms 3Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma 2Locally Advanced (Inoperable) or Metastatic Breast Cancer 2Hematologic Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Moderate Hepatic Impairment 1Meningioma 1Healthy Participants 1Glioma 1Esophageal Neoplasms 1Disease Progression 1Colorectal Neoplasms 1Colonic Neoplasms 1Chondrosarcoma 1Carcinosarcoma 1

Interventions

ivosidenib 1enasidenib 1durvalumab 1capivasertib 1Weight-Bearing 1Taxes 1Range of Motion, Articular 1Pharmacogenomic Testing 1Paclitaxel 1Immunoglobulin G 1HhAntag691 1Gemcitabine 1Disulfides 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × capivasertib × 90 days × Clear all
NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡